SCHEMBL5865430

SCHEMBL5865430

CN(OC(=O)/C=C/C(=O)ON(C)c1ccnc(C2=Cc3ccccc3CC2)c1)c1ccnc(C2=Cc3ccccc3CC2)c1

nearest known ligand 0.38

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 4/20 0.38
CYP11B1 P15538 3/20 0.38
CYP19A1 P11511 2/20 0.38
NISCH Q9Y2I1 1/20 0.37
PTGS2 P35354 1/20 0.33
GRIN2D O15399 1/20 0.32
GRIN3B O60391 1/20 0.32
CHRM1 P11229 1/20 0.32
ADRA1D P25100 1/20 0.32
ADRA1A P35348 1/20 0.32
ADRA1B P35368 1/20 0.32
GRIN1 Q05586 1/20 0.32
GRIN2A Q12879 1/20 0.32
GRIN2B Q13224 1/20 0.32
GRIN2C Q14957 1/20 0.32
GRIN3A Q8TCU5 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27590123 0.74 CYP19A1 (0.38) CYP11B2CYP11B1CYP19A1NISCHPTGS2
Fumaric Acid SCHEMBL27590124 0.74 GRIN2D (0.40) CYP11B2CYP11B1CYP19A1NISCHPTGS2
Fumaric Acid SCHEMBL5865432 0.74 GRIN2D (0.40) CYP11B2CYP11B1CYP19A1NISCHPTGS2
SCHEMBL5865220 0.70 GRIN2D (0.47) CYP11B2CYP11B1CYP19A1NISCHPTGS2
SCHEMBL7111101 0.70 GRIN2D (0.57) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL27590114 0.70 GPR35 (0.40) CYP11B2CYP11B1CYP19A1NISCHGRIN2D
Fumaric Acid SCHEMBL5865428 0.70 LOXL2 (0.43) CYP11B2CYP11B1CYP19A1NISCH
SCHEMBL5864929 0.69 CYP11B2 (0.37) CYP11B2CYP11B1CYP19A1NISCHPTGS2
SCHEMBL27590116 0.69 GRIN2D (0.38) CYP11B2CYP11B1CYP19A1NISCHGRIN2D
SCHEMBL5865391 0.69 GRIN2D (0.46) CYP19A1GRIN2DGRIN3BGRIN1GRIN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1837195-A Pyridine derivatives as nmda-receptor subtype blockers HOFFMANN LA ROCHE (CH) 2006-09-27 CN disclosed
US-7034044-B2 Conjugated aromatic compounds with a pyridine substituent HOFFMANN-LA ROCHE INC. (US) 2006-04-25 US disclosed
US-20060058354-A1 Conjugated aromatic compounds with a pyridine substituent ALANINE ALEXANDER 2006-03-16 US disclosed
US-6951875-B2 Conjugated aromatic compounds with a pyridine substituent HOFFMANN-LA ROCHE INC. (US) 2005-10-04 US disclosed
US-20040068118-A1 Conjugated aromatic compounds with a pyridine substituent ALANINE ALEXANDER (FR) 2004-04-08 US disclosed
US-20030144525-A1 Conjugated aromatic compounds with a pyridine substituent HOFFMANN-LA ROCHE INC. 2003-07-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040068118-A1 Conjugated aromatic compounds with a pyridine substituent GRIN2B, GRIN1, GRIN2C CYP11B2 317/4885CYP11B1 359/4885CYP19A1 1693/4885
US-20030144525-A1 Conjugated aromatic compounds with a pyridine substituent GRIN2B, GRIN1, GRIN2C CYP11B2 317/4885CYP11B1 359/4885CYP19A1 1693/4885
US-20060058354-A1 Conjugated aromatic compounds with a pyridine substituent GRIN2B, GRIN3A, GRIN2C CYP11B2 379/4885CYP11B1 445/4885CYP19A1 2025/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.